Shiono P H, Klebanoff M A, Nugent R P, Cotch M F, Wilkins D G, Rollins D E, Carey J C, Behrman R E
Center for the Future of Children, David and Lucille Pakcard Foundation, Los Altos, CA 94022.
Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):19-27. doi: 10.1016/0002-9378(95)90078-0.
Our aim was to evaluate prospectively the effects of cocaine and marijuana use on pregnancy outcomes.
A prospective multicenter cohort study was conducted at seven university-based prenatal clinics in the United States from 1984 to 1989. The cohort described herein consisted of a multiethnic population of 7470 pregnant women. Information on the use of drugs was obtained from personal interviews at entry to the study and assays of serum obtained during pregnancy. Pregnancy outcome data (low birth weight [< 2500 gm], preterm birth [< 37 weeks' gestation], and abruptio placentae) were obtained with a standardized study protocol.
A total of 2.3% of the women used cocaine and 11.0% used marijuana during pregnancy. Cocaine use was not associated with having a low-birth-weight infant (adjusted odds ratio 0.7, 95% confidence interval 0.4 to 1.3) or a preterm birth (1.3, 0.9 to 2.0). There was no association between short-term exposure to cocaine and preterm delivery (1.1, 0.3 to 4.0). However, cocaine use was strongly associated with abruptio placentae (adjusted odds ratio 4.2, 1.9 to 9.5). Marijuana use was not associated with low birth weight (1.1, 0.9 to 1.5), preterm delivery (1.1, 0.8 to 1.3) or abruptio placentae (1.3, 0.6 to 2.8). By comparison, 35% of the women smoked cigarettes during pregnancy, and cigarette smoking was positively associated with low birth weight (1.5, 1.2 to 1.8).
In this population of women receiving prenatal care, cocaine use was uncommon and was not related to most adverse birth outcomes. Marijuana use was relatively common and was not related to adverse pregnancy outcomes. Tobacco is still the most commonly abused drug during pregnancy, 15% of all cases of low birth weight in this study could have been prevented if women did not smoke cigarettes during pregnancy.
我们的目的是前瞻性评估可卡因和大麻使用对妊娠结局的影响。
1984年至1989年在美国七家大学附属产前诊所进行了一项前瞻性多中心队列研究。本文所述队列由7470名多民族孕妇组成。关于药物使用的信息通过研究入组时的个人访谈以及孕期采集的血清检测获得。妊娠结局数据(低出生体重[<2500克]、早产[<37孕周]和胎盘早剥)通过标准化研究方案获得。
共有2.3%的女性在孕期使用可卡因,11.0%使用大麻。使用可卡因与低出生体重婴儿(校正比值比0.7,95%置信区间0.4至1.3)或早产(1.3,0.9至2.0)无关。短期接触可卡因与早产之间无关联(1.1,0.3至4.0)。然而,使用可卡因与胎盘早剥密切相关(校正比值比4.2,1.9至9.5)。使用大麻与低出生体重(1.1,0.9至1.5)、早产(1.1,0.8至1.3)或胎盘早剥(1.3,0.6至2.8)无关。相比之下,35%的女性在孕期吸烟,吸烟与低出生体重呈正相关(1.5,1.2至1.8)。
在这群接受产前护理的女性中,可卡因使用不常见,且与大多数不良出生结局无关。大麻使用相对常见,且与不良妊娠结局无关。烟草仍是孕期最常滥用的药物,如果女性孕期不吸烟,本研究中15%的低出生体重病例本可避免。